Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Antidepressive Agents and Fatty Acids, Omega-3

Research Papers that Mention the Interaction

BACKGROUND Extant literature shows that adjuvant omega-3-polyunsaturated fatty acids (O3PUFAs) to a standard antidepressant medication impacts favorably on symptoms of depression in participants with major depressive disorders (MDD).
Journal of psychiatric research  •  2018  |  View Paper
Nutritional supplements such as omega-3 have been found to produce beneficial effects in the management of treatment-resistant depression when administered in combination with the ongoing antidepressant treatment.
Presse medicale  •  2016  |  View Paper
Pilot studies in unipolar depression report an improvement in depression when omega-3 fatty acids are given with antidepressants.
PloS one  •  2016  |  View Paper
Nevertheless, adjunctive prescription of omega-3 with antidepressants , or in people with dietary deficiency, may be beneficial.
Nutrition reviews  •  2009  |  View Paper
CONTEXT Studies of depressed psychiatric patients have shown that antidepressant efficacy can be increased by augmentation with omega-3 fatty acids.
JAMA  •  2009  |  View Paper
We previously reported that combined fluoxetine administration at antidepressant doses renders additive antidepressant effects, whereas non-antidepressant doses potentiate the omega-3 fatty acid antidepressant effect.
Journal of pharmaceutical sciences  •  2014  |  View Paper
Beneficial effects of combined treatment were also observed at sub-effective doses (1 mg/kg/day) of fluoxetine or mirtazapine, since in combination with omega-3 fatty acids (720 mg/kg/day), antidepressants potentiated omega-3 antidepressant-like effects.
European journal of pharmacology  •  2010  |  View Paper
LCn-3 fatty acid supplementation has been shown to augment the therapeutic efficacy of antidepressant , mood-stabilizer, and second generation antipsychotic medications, and may additionally mitigate adverse cardiometabolic side-effects.
PharmaNutrition  •  2013  |  View Paper